This is a routine CCO departure with a planned transition and advisory retention — no red flags. The cross-filing DEFA14A (4 days prior) relates to an equity plan amendment vote, not this departure. Monitor the next 10-Q for any further executive changes or operational disruption commentary.
Price Chart
Executive Summary
OptimizeRx disclosed the separation of Chief Commercial Officer Theresa Greco, effective June 15, 2026, with a separation agreement providing 12 months of base salary continuation ($380,000), a $209,000 lump-sum bonus, and COBRA reimbursement. Greco will serve as an advisor for 12 months with continued equity vesting. The departure was previously disclosed in the Q1 2026 10-Q and appears planned, not unexpected.
Key Facts
- Chief Commercial Officer Theresa Greco to depart effective June 15, 2026
- Separation agreement includes 12 months base salary continuation ($380,000/year), $209,000 lump-sum bonus, and COBRA reimbursement
- Greco will provide advisory services for 12 months through June 15, 2027, with continued equity vesting
- Non-compete and non-solicitation restrictions apply for 12 months
- Departure was previously disclosed in the Q1 2026 10-Q, indicating a planned transition
Financial Impact
Total cash consideration to Greco of approximately $589,000 ($380,000 salary + $209,000 bonus) plus COBRA costs — immaterial relative to company market cap of $101M
Risk Factors
- Loss of commercial leadership could slow sales execution during transition
- Advisory role may not fully replace active CCO responsibilities
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-065810 |
| Document: 0001213900-26-065810-index-headers.html | 0001213900-26-065810 |
| Document: 0001213900-26-065810-index.html | 0001213900-26-065810 |
| Document: 0001213900-26-065810.txt | 0001213900-26-065810 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | Press Release | $9.15 | awaiting T+20 | — | $9.23 (+0.82%) |
Oct 21, 2026 5d ago | SC 13G/A | $9.37 | awaiting T+20 | — | $9.23 (−1.55%) |
Sep 22, 2026 4w ago | Institutional Cluster | $7.62 $8.93 | ▲ +17.19% | ▲ +17.75% | $9.23 (+21.06%) |
Aug 12, 2026 10w ago | Press Release | $8.78 $7.29 | ▼ −16.97% | ▼ −15.22% | $9.23 (+5.07%) |
Jun 12, 2026 19w ago | 8-K | $5.32 $6.55 | ▲ +23.12% | ▲ +23.87% | $9.23 (+73.40%) |
Jun 11, 2026 19w ago | Institutional Cluster | $5.28 $6.28 | ▲ +18.94% | ▲ +17.05% | $9.23 (+74.72%) |
Jun 5, 2026 20w ago | 8-K | $5.05 $6.35 | ▲ +25.74% | ▲ +24.11% | $9.23 (+82.67%) |
Jun 1, 2026 21w ago | DEFA14A | $5.38 $5.72 | ▲ +6.32% | ▲ +7.62% | $9.23 (+71.47%) |
May 21, 2026 22w ago | Press Release | $4.94 $4.70 | ▼ −4.86% | ▼ −5.19% | $9.23 (+86.74%) |
May 12, 2026 23w ago | Press Release | $4.92 $5.28 | ▲ +7.32% | ▲ +7.93% | $9.23 (+87.50%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers